Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

Article information

Acute Crit Care. 2023;38(4):516-516

Publication date (electronic) : 2023 November 20

doi : https://doi.org/10.4266/acc.2022.01424.e1

Hyeon-Jeong Lee ¹^,^*, Hye Jin Jang ²^,^*, Won-Il Choi ², Joonsung Joh ³, Junghyun Kim ³, Jungeun Park ¹, Miyoung Choi ¹

¹Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea

²Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Myongji Hospital, Hanyang University, Goyang, Korea

³Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Korea

Corresponding author: Miyoung Choi Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Health and Welfare Administration Town, 400 Neungdong-ro, Gwangjin-gu, Seoul 04933, Korea Tel: +82-2-2174-2867, Fax: +82-2-747-4916, Email: myhams95@gmail.com

*These authors contributed equally to this work.

Received 2023 November 28; Accepted 2023 November 20.

Acute and Critical Care 2023;38:160-71

https://doi.org/10.4266/acc.2022.01424

In the article entitled “Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis,” there was an error in Results section of the abstract. In the sentence “In the severe patients, the incidence of thromboembolic and bleeding events in the therapeutic or intermediate.” should be:

“In the severe group, the incidence of thromboembolic and bleeding events in the therapeutic and prophylaxis groups was not statistically different.”

Furthermore, the city of Myongji Hospital was inadvertently omitted, and it should be included as “Goyang.”

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.